Report period | 2019 | 2020 | 2021 | 2022 | 2023 | Q3 24 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
SRDX:US | SurModics, Inc. | Common share | - | US8688731004 | $27.66 |
Company name | SurModics |
---|---|
Tags | #medtech |
Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment |
Business address | 9924 W 74TH ST EDEN PRAIRIE MN 55344 9525007000 |
Mailing address | 9924 WEST 74TH ST EDEN PRAIRIE MN 55344 |
Website | www.surmodics.com |
Information disclosure | www.sec.gov |